(CPT) Camden Property Trust - Ratings and Ratios
Multifamily,Apartment,Communities,Leasing,Management
CPT EPS (Earnings per Share)
CPT Revenue
Description: CPT Camden Property Trust October 31, 2025
Camden Property Trust (NYSE:CPT) is an S&P 500-listed REIT focused on multifamily apartments. It currently owns and manages 173 properties with 59,046 units across the United States, and its development pipeline of four projects will raise the portfolio to 177 properties and roughly 60,600 homes once completed. The firm is also noted for its workplace culture, earning a spot on Fortune’s “100 Best Companies to Work For” for 18 straight years, most recently ranking #18.
Key operational metrics that analysts watch include an occupancy rate that hovered around 96% in FY 2023 and same-store rent growth of about 5% year-over-year, both above the industry median. The company’s balance sheet remains relatively strong, with a net debt-to-EBITDA ratio near 5.0×, giving it flexibility to fund its $1.2 billion development pipeline. Sector-wide, the multifamily market is being driven by sustained demand from millennials and Gen Z renters, limited new supply in high-growth metros, and a macro environment where rising interest rates have made home-ownership less affordable, bolstering rental demand.
If you want a deeper, data-rich view of CPT’s valuation dynamics, a quick look at ValueRay’s analyst toolkit can help you surface the most material assumptions and stress-test scenarios.
CPT Stock Overview
| Market Cap in USD | 10,630m |
| Sub-Industry | Multi-Family Residential REITs |
| IPO / Inception | 1993-07-22 |
CPT Stock Ratings
| Growth Rating | -20.8% |
| Fundamental | 61.5% |
| Dividend Rating | 65.3% |
| Return 12m vs S&P 500 | -24.7% |
| Analyst Rating | 3.68 of 5 |
CPT Dividends
| Dividend Yield 12m | 4.11% |
| Yield on Cost 5y | 5.01% |
| Annual Growth 5y | 5.55% |
| Payout Consistency | 96.2% |
| Payout Ratio | 4.0% |
CPT Growth Ratios
| Growth Correlation 3m | -68.1% |
| Growth Correlation 12m | -65% |
| Growth Correlation 5y | -6.5% |
| CAGR 5y | 1.41% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.04 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.12 |
| Sharpe Ratio 12m | 0.67 |
| Alpha | -24.19 |
| Beta | 0.808 |
| Volatility | 22.00% |
| Current Volume | 1241.9k |
| Average Volume 20d | 1067.4k |
| Stop Loss | 98.7 (-3.1%) |
| Signal | 1.03 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (156.0m TTM) > 0 and > 6% of Revenue (6% = 93.6m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.53pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 2.65% (prev -19.67%; Δ 22.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 792.8m > Net Income 156.0m (YES >=105%, WARN >=100%) |
| Net Debt (-33.1m) to EBITDA (893.3m) ratio: -0.04 <= 3.0 (WARN <= 3.5) |
| Current Ratio 60.66 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (109.4m) change vs 12m ago 0.90% (target <= -2.0% for YES) |
| Gross Margin 61.19% (prev 61.79%; Δ -0.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 17.15% (prev 17.06%; Δ 0.09pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.24 (EBITDA TTM 893.3m / Interest Expense TTM 134.2m) >= 6 (WARN >= 3) |
Altman Z'' -0.34
| (A) 0.00 = (Total Current Assets 42.0m - Total Current Liabilities 692.0k) / Total Assets 9.12b |
| (B) -0.11 = Retained Earnings (Balance) -1.01b / Total Assets 9.12b |
| (C) 0.03 = EBIT TTM 300.6m / Avg Total Assets 9.10b |
| (D) -0.23 = Book Value of Equity -1.00b / Total Liabilities 4.46b |
| Total Rating: -0.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.53
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 2.87% = 1.44 |
| 3. FCF Margin 26.55% = 6.64 |
| 4. Debt/Equity 0.83 = 2.16 |
| 5. Debt/Ebitda -0.04 = 2.50 |
| 6. ROIC - WACC (= -3.27)% = -4.09 |
| 7. RoE 3.35% = 0.28 |
| 8. Rev. Trend 83.14% = 6.24 |
| 9. EPS Trend -42.51% = -2.13 |
What is the price of CPT shares?
Over the past week, the price has changed by +4.35%, over one month by -1.11%, over three months by -4.49% and over the past year by -10.50%.
Is Camden Property Trust a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CPT is around 95.37 USD . This means that CPT is currently overvalued and has a potential downside of -6.33%.
Is CPT a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 14
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CPT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 120.9 | 18.7% |
| Analysts Target Price | 120.9 | 18.7% |
| ValueRay Target Price | 104.8 | 2.9% |
CPT Fundamental Data Overview November 02, 2025
P/E Trailing = 69.5664
P/E Forward = 62.5
P/S = 6.77
P/B = 2.4322
P/EG = 8.96
Beta = 0.808
Revenue TTM = 1.56b USD
EBIT TTM = 300.6m USD
EBITDA TTM = 893.3m USD
Long Term Debt = 3.83b USD (from longTermDebt, last quarter)
Short Term Debt = 515.6m USD (from shortTermDebt, last quarter)
Debt = 3.83b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -33.1m USD (from netDebt column, last quarter)
Enterprise Value = 14.42b USD (10.63b + Debt 3.83b - CCE 33.1m)
Interest Coverage Ratio = 2.24 (Ebit TTM 300.6m / Interest Expense TTM 134.2m)
FCF Yield = 2.87% (FCF TTM 414.3m / Enterprise Value 14.42b)
FCF Margin = 26.55% (FCF TTM 414.3m / Revenue TTM 1.56b)
Net Margin = 9.99% (Net Income TTM 156.0m / Revenue TTM 1.56b)
Gross Margin = 61.19% ((Revenue TTM 1.56b - Cost of Revenue TTM 605.7m) / Revenue TTM)
Gross Margin QoQ = 61.16% (prev 61.60%)
Tobins Q-Ratio = 1.58 (Enterprise Value 14.42b / Total Assets 9.12b)
Interest Expense / Debt = 0.92% (Interest Expense 35.4m / Debt 3.83b)
Taxrate = 1.47% (1.23m / 83.8m)
NOPAT = 296.2m (EBIT 300.6m * (1 - 1.47%))
Current Ratio = 60.66 (Total Current Assets 42.0m / Total Current Liabilities 692.0k)
Debt / Equity = 0.83 (Debt 3.83b / totalStockholderEquity, last quarter 4.59b)
Debt / EBITDA = -0.04 (Net Debt -33.1m / EBITDA 893.3m)
Debt / FCF = -0.08 (Net Debt -33.1m / FCF TTM 414.3m)
Total Stockholder Equity = 4.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.71% (Net Income 156.0m / Total Assets 9.12b)
RoE = 3.35% (Net Income TTM 156.0m / Total Stockholder Equity 4.66b)
RoCE = 3.54% (EBIT 300.6m / Capital Employed (Equity 4.66b + L.T.Debt 3.83b))
RoIC = 3.58% (NOPAT 296.2m / Invested Capital 8.28b)
WACC = 6.85% (E(10.63b)/V(14.46b) * Re(8.99%) + D(3.83b)/V(14.46b) * Rd(0.92%) * (1-Tc(0.01)))
Discount Rate = 8.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 78.29% ; FCFE base≈394.2m ; Y1≈482.0m ; Y5≈805.6m
Fair Price DCF = 107.7 (DCF Value 11.51b / Shares Outstanding 106.9m; 5y FCF grow 23.81% → 3.0% )
EPS Correlation: -42.51 | EPS CAGR: -59.03% | SUE: -0.51 | # QB: 0
Revenue Correlation: 83.14 | Revenue CAGR: 2.17% | SUE: 1.67 | # QB: 2
Additional Sources for CPT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle